Cited by 365Immune Response and InflammationImmune cells in cancerCytokine Signaling Pathways and Interactions

Stimulatory and inhibitory effects of interleukin (IL)-4 and IL-13 on the production of cytokines by human peripheral blood mononuclear cells: priming for IL-12 and tumor necrosis factor alpha production

Open access
D'Andrea, A, Ma, X, Aste-Amezaga, M, Paganin, C, Trinchieri, G·1995·The Journal of experimental medicine

Abstract

The production of cytokines in monocytes/macrophages is regulated by several different cytokines that have activating or inhibitory effects. Interleukin (IL)-10, IL-4, IL-13, and transforming growth factor (TGF)-beta are usually considered to be the most important macrophage-deactivating factors, with inhibitory effects on cytokine production. Unlike IL-10 and TGF-beta, which appear to act as downmodulators of many phagocytic cell functions, the mode of action of IL-4 and IL-13 is more complex. Addition of IL-4 and IL-13 to peripheral blood mononuclear cell (PBMC) cultures inhibited production of IL-12, tumor necrosis factor (TNF)-alpha, IL-10, and IL-1 beta induced by lipopolysaccharide (LPS) or Staphylococcus aureus added simultaneously with the cytokines. However, pretreatment of PBMC with IL-4 or IL-13 for > or = 20 h enhanced the production of IL-12 and TNF-alpha in response to LPS or S. aureus several fold in these cells; this IL-4-induced priming for the two cytokines was inhibited by anti-IL-4 neutralizing antibodies. IL-4 priming also enhanced the accumulation of IL-12 and TNF-alpha mRNA induced by LPS and S. aureus. The enhanced accumulation of transcripts for the IL-12 p35 and p40 chains by IL-4 priming was reflected in enhanced secretion of both the IL-12 free p40 chain and the p70 heterodimer. These results suggest an unexpected complexity in the regulatory role of IL-4 and IL-13 in immune responses.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1084/jem.181.2.537

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The induction of TNF-a and IL-12 production by LPS can be significantly dampened in the presence of IL-4.

    “for example, the induction of TNF-a and IL-12 production by the pro-inflammatory (M1 polarizing) cytokine, LPS, can be significantly dampened in the presence of IL-4; a M2 polarizing cytokine produced by nearby M2 macrophages, basophils and mast cells [26].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 55 · Cited by 365

Authors
D'Andrea, A., Ma, X., Aste-Amezaga, M., Paganin, C., & Trinchieri, G.
Affiliations
  • Wistar Institute of Anatomy and Biology, Philadelphia, Pennsylvania 19104.
  • The Wistar Institute (US)
Venue
The Journal of experimental medicine
Published
1995-02-01
Volume
181
Issue
2
Pages
537-546
ISSN
  • 0022-1007 (ISSN-L)
  • 1540-9538
OpenAlex
W2145677005
Cited by
365
References
55
Citations by year
2026: 1 · 2024: 2 · 2023: 2 · 2022: 6 · 2021: 2 · 2020: 2 · 2019: 3 · 2018: 2 · 2017: 7 · 2016: 3 · 2015: 6 · 2014: 12 · 2013: 8 · 2012: 13
FWCI
14.33
Type
journal article
Language
en
Open access
Locations
  • The Journal of Experimental Medicine (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
  • PubMed Central (publishedVersion, cc-by-nc-sa)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (5r01ca032898-13, 10815)
  • National Cancer Institute (CA 32898, CA-20833, CA-10815, P30CA010815)
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
  • Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
  • Health Sciences › Medicine › Oncology › Cytokine Signaling Pathways and Interactions
Keywords
IL-4, IL-13, IL-12, TNF-α, peripheral blood mononuclear cells, macrophage activation, cytokine priming, lipopolysaccharide, Staphylococcus aureus, IL-10, TGF-beta, mRNA accumulation, cytokine regulation
MeSH terms
Animals, Cell Line, Cricetinae, Humans, Kinetics, Leukocytes, Mononuclear, Staphylococcus aureus, Tumor Necrosis Factor-alpha, Interleukin-4, Transforming Growth Factor beta, CHO Cells, Interleukin-10, Interleukin-12, Interleukin-13

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review